Evidence map›Paper›PMID 34504070›Full record

ArticleNature communications2021

Variant PCGF1-PRC1 links PRC2 recruitment with differentiation-associated transcriptional inactivation at target genes.

Hiroki Sugishita, Takashi Kondo, Shinsuke Ito, Manabu Nakayama, Nayuta Yakushiji-Kaminatsui, Eiryo Kawakami, Yoko Koseki, Yasuhide Ohinata, Jafar Sharif, Mio Harachi and 3 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Hiroki SugishitaLaboratory for Developmental Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.ORCID 0000-0002-6561-8261
Takashi KondoLaboratory for Developmental Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Shinsuke ItoLaboratory for Developmental Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Manabu NakayamaLaboratory of Medical Omics Research, Kazusa DNA Research Institute, Kisarazu, Japan.
Nayuta Yakushiji-KaminatsuiLaboratory for Developmental Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.ORCID 0000-0001-7324-1161
Eiryo KawakamiArtificial Intelligence Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.ORCID 0000-0001-9955-4342
Yoko KosekiLaboratory for Developmental Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Yasuhide OhinataLaboratory for Developmental Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Jafar SharifLaboratory for Developmental Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Mio HarachiLaboratory for Developmental Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Neil P BlackledgeDepartment of Biochemistry, University of Oxford, Oxford, UK.
Robert J KloseDepartment of Biochemistry, University of Oxford, Oxford, UK.ORCID 0000-0002-8726-7888
Haruhiko KosekiLaboratory for Developmental Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan. haruhiko.koseki@riken.jp.ORCID 0000-0001-8424-5854
RIKEN Center for Integrative Medical Sciences · JPChiba University · JPUniversity of Oxford · GBBunkyo University · JPKazusa DNA Research Institute · JP

Funding

Wellcome TrustWellcome Trust 209400/Z/17/Z
6 · The paper itself

Abstract

Polycomb repressive complexes-1 and -2 (PRC1 and 2) silence developmental genes in a spatiotemporal manner during embryogenesis. How Polycomb group (PcG) proteins orchestrate down-regulation of target genes upon differentiation, however, remains elusive. Here, by differentiating embryonic stem cells into embryoid bodies, we reveal a crucial role for the PCGF1-containing variant PRC1 complex (PCGF1-PRC1) to mediate differentiation-associated down-regulation of a group of genes. Upon differentiation cues, transcription is down-regulated at these genes, in association with PCGF1-PRC1-mediated deposition of histone H2AK119 mono-ubiquitination (H2AK119ub1) and PRC2 recruitment. In the absence of PCGF1-PRC1, both H2AK119ub1 deposition and PRC2 recruitment are disrupted, leading to aberrant expression of target genes. PCGF1-PRC1 is, therefore, required for initiation and consolidation of PcG-mediated gene repression during differentiation.

Indexed as

Gene Expression Regulation, DevelopmentalAnimalsCell DifferentiationEmbryoid BodiesEmbryo, MammalianHistonesKruppel-Like Factor 4Kruppel-Like Transcription FactorsMiceMice, TransgenicMouse Embryonic Stem CellsPlatelet-Derived Growth FactorPolycomb Repressive Complex 1Polycomb Repressive Complex 2Primary Cell CultureSOXC Transcription Factorsgrainy head-like 2 protein, mouseHistonesKruppel-Like Factor 4Kruppel-Like Transcription FactorsPcgf1 protein, mousePlatelet-Derived Growth Factorplatelet-derived growth factor APolycomb Repressive Complex 1Polycomb Repressive Complex 2Sox4 protein, mouseSOXC Transcription FactorsT-Box Domain ProteinsTbx3 protein, mouseTranscription Factors

Identifiers

PMID34504070
PMCPMC8429492
OpenAlexW3197596394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.